Related Experiment Videos

Functional characterization of five constitutively activating thyrotrophin receptor mutations

P Wonerow1, S Chey, D Führer

  • 1Medizinische Klinik und Poliklinik III, Universität Leipzig, Leipzig, Germany.

Clinical Endocrinology
|September 30, 2000
PubMed
Abstract

Insights

Gain of function mutations in the thyrotrophin receptor (TSHR) were studied. A deletion mutant showed constitutive activity for both cAMP and inositol phosphate pathways, suggesting different TSHR active conformations.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Signaling

Background:

  • Gain of function mutations in the thyrotrophin receptor (TSHR) alter receptor function, impacting cAMP and inositol phosphate (IP) accumulation, cell surface expression, and TSH affinity.
  • Understanding these mutations is crucial for elucidating TSHR signaling pathways and associated thyroid disorders.

Purpose of the Study:

  • To compare the functional characteristics of five constitutively activating TSHR mutations, including four point mutations and one deletion mutant.
  • To investigate the effects of these mutations on cAMP and IP accumulation, cell surface expression, and TSHR regulation.

Main Methods:

  • Transiently expressed wild-type TSHR and mutant TSHRs (S505N, L629F, I630L, V656F, and deletion 613-621) in COS-7 cells.
  • Assessed basal and stimulated cAMP and IP accumulation, cell surface expression (FACS, ELISA), and TSHR downregulation post-transfection.

Main Results:

  • Despite varying specific constitutive activity and cell surface expression levels, basal cAMP accumulation was uniform across mutants.
  • Point mutations did not constitutively activate the phospholipase C cascade, whereas the deletion mutant (613-621) exhibited constitutive IP pathway activity.
  • All mutants showed TSH-stimulated receptor downregulation, independent of the phospholipase C pathway.

Conclusions:

  • Uniform basal cAMP levels suggest regulation within the COS-7 overexpression system, likely due to receptor downregulation.
  • The TSHR deletion mutant (613-621) displayed constitutive activity in both Galphas and Galphaq/11 pathways.
  • The contrasting responses to TSH for cAMP and IP accumulation in the deletion mutant support the model of distinct TSHR active conformations.

Related Concept Videos